N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma. This evidence concerns the gene METTL14 and hereditary clear cell renal cell carcinoma.